| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |